Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S. Mejía Loza"'
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100596- (2022)
Introduction and Objectives: Controlled clinical studies have demonstrated the benefits of albumin in decompensated cirrhotic patients with ascites, elevated creatinine, spontaneous bacterial peritonitis, refractory ascites, hepatorenal syndrome and
Externí odkaz:
https://doaj.org/article/18a7d32718ea4c289c72fa8a060c3759
Publikováno v:
Annals of Hepatology. 27:100807
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32a0e4dcb4098d93ef91a9164a668da0
https://doi.org/10.1016/j.aohep.2022.100807
https://doi.org/10.1016/j.aohep.2022.100807
Publikováno v:
Annals of Hepatology. 27:100808
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fcf22439a0b921b451fdaa25f622b8c
https://doi.org/10.1016/j.aohep.2022.100808
https://doi.org/10.1016/j.aohep.2022.100808
Autor:
R Chicas López, S Mejía Loza, O García Rodas, L Pinto García, F Sánchez Salinas, C Jaen Villanueva, P Guillermo, G Castañón García
Publikováno v:
Annals of Hepatology. 27:100816
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507d567e06c898fa15be6b732e492403
https://doi.org/10.1016/j.aohep.2022.100816
https://doi.org/10.1016/j.aohep.2022.100816
Publikováno v:
Annals of Hepatology. 27:100811
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14cb381d22383ac42d127d6783d42b33
https://doi.org/10.1016/j.aohep.2022.100811
https://doi.org/10.1016/j.aohep.2022.100811
Autor:
F. Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss, Pp 100610-(2022)
Introduction and Objectives: Clinical trials demonstrated the efficacy and safety of direct antiviral agents (DAA) to treat hepatitis C virus infection (HCV) in patients with decompensated cirrhosis (DC); however, very few real-world studies have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5731efa76f76d3907a1c9d4f3f96f26
https://doi.org/10.1016/j.aohep.2021.100610
https://doi.org/10.1016/j.aohep.2021.100610
Autor:
F- Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss, Pp 100607-(2022)
Introduction and Objectives: If direct antiviral agents (DAA) are related to the development of HCC is controversial; therefore, exploring risk factors are crucial. We aimed to determine factors related to the development of hepatocellular carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e3dd495ffb38ef3bd78affa2d6b7c8
https://doi.org/10.1016/j.aohep.2021.100607
https://doi.org/10.1016/j.aohep.2021.100607